Signal #165166 · SEC 8-K

$ENTX SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $ENTX filing catalyst

Why did $ENTX trigger an AI stock catalyst alert?

$ENTX triggered a Stock Catalyst AI alert on 2026-11-06 21:15:33 UTC for a SEC 8-K filing (AI Score: +1.5/10). Headline: Entera Bio Reports Q3 2026 Results: Cash Reaches $265.9M to Fund Phase 3. Key points: - Net loss expanded to $15.6M ($0.11/share) vs $3.2M ($0.07/share) in prior year, driven by non-cash warrant revaluations. - Cash and equivalents surged to $265.9M from $7.1M at year-end 2025 following capital raises. - Clinical preparations ongoing for EB613 Phase 3 trial site activation in late 2026.

How did $ENTX stock react after the SEC filing?

After the SEC 8-K for $ENTX, observed market reaction: T0 price $3.14. Past moves do not guarantee future results.

Where can I get real-time $ENTX SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $ENTX via Telegram and the VIP Web Terminal from €10/month.

$ENTX

$ENTX – Entera Bio Reports Q3 2026 Results: Cash Reaches $265.9M to Fund Phase 3

Entera Bio Ltd.

2026-11-06 21:15:33 UTC · SEC 8-K · All $ENTX

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+1.5 / 10)

Net loss expanded to $15.6M ($0.11/share) vs $3.2M ($0.07/share) in prior year, driven by non-cash warrant revaluations.
Cash and equivalents surged to $265.9M from $7.1M at year-end 2025 following capital raises.
Clinical preparations ongoing for EB613 Phase 3 trial site activation in late 2026.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →